Change in Expression of ER, bcl-2 and MIB1 on Primary Tamoxifen and Relation to Response in ER Positive Breast Cancer

By Kenny F.S.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 2, 2001-01 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer

By Keen J.C.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 2, 1997-06 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite

The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen

By Billgren A.-M.   Rutqvist L.E.   Johansson H.   Hagerstrom T.   Skoog L.  

European Journal of Cancer, Vol. 36, Iss. 11, 2000-07 ,pp. : 1374-1380

Elsevier

Access to resources Recommend Favorite

MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer

By Cozzi Paul   Wang Jian   Delprado Warick   Perkins Alan   Allen Barry   Russell Pamela   Li Yong  

Clinical and Experimental Metastasis, Vol. 22, Iss. 7, 2005-11 ,pp. : 565-573

Springer Publishing Company

Access to resources Recommend Favorite

Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction

By Reddy P.K.   Gold D.V.   Cardillo T.M.   Goldenberg D.M.   Li H.   Burton J.D.  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 397-404

Elsevier

Access to resources Recommend Favorite